March 18, 2013

Quest 5-in-1 Demential Test May Help Rule Out Alzheimer’s

By Logan Lafferty

Quest’s testing panel may not turn up a huge number of treatable cases of dementia. Reversible forms are much less common than Alzheimer’s disease and others such as vascular dementia, said David Knopman, a member of the American Academy of Neurology and a professor of neurology at the Mayo Clinic in Rochester, Minnesota. “Unfortunately and disappointingly, it is exceedingly rare” to find cases of treatable dementia, he said in a telephone interview. Knopman was part of the group that wrote practice guidelines in 2001 for screening tests.


Bloomberg by Meg Tirrell

Tags: alzheimer's disease, American Academy of Neurology, Bloomberg, dementia, Dr. David Knopman, Mayo Clinic Rochester, Neurology, Quest, treatable dementia, vascular dementia

Contact Us · Privacy Policy